These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 32861338)
1. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic. Lim S; DeBruin DA; Leider JP; Sederstrom N; Lynfield R; Baker JV; Kline S; Kesler S; Rizza S; Wu J; Sharp RR; Wolf SM Mayo Clin Proc; 2020 Sep; 95(9):1946-1954. PubMed ID: 32861338 [TBL] [Abstract][Full Text] [Related]
2. Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism. Weber E; Bliton MJ Am J Bioeth; 2020 Sep; 20(9):31-33. PubMed ID: 32840451 [No Abstract] [Full Text] [Related]
3. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. Ison MG; Wolfe C; Boucher HW JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438 [No Abstract] [Full Text] [Related]
5. Audio Interview: New Data on Remdesivir in Covid-19. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948 [No Abstract] [Full Text] [Related]
6. A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge. White DB; Angus DC JAMA; 2020 Jul; 324(4):329-330. PubMed ID: 32579158 [No Abstract] [Full Text] [Related]
7. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
8. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019. Montastruc F; Thuriot S; Durrieu G Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580 [TBL] [Abstract][Full Text] [Related]
9. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812 [TBL] [Abstract][Full Text] [Related]
10. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. Sun D AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279 [TBL] [Abstract][Full Text] [Related]
11. Remdesivir: First Approval. Lamb YN Drugs; 2020 Sep; 80(13):1355-1363. PubMed ID: 32870481 [TBL] [Abstract][Full Text] [Related]
12. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment. Davies M; Osborne V; Lane S; Roy D; Dhanda S; Evans A; Shakir S Drug Saf; 2020 Jul; 43(7):645-656. PubMed ID: 32468196 [TBL] [Abstract][Full Text] [Related]
13. A Review of Remdesivir for COVID-19: Data to Date. Mehta M; Shyh GI Cardiol Rev; 2020; 28(6):332-334. PubMed ID: 32773440 [TBL] [Abstract][Full Text] [Related]
14. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19. Chua KP; Conti RM JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187 [No Abstract] [Full Text] [Related]
15. Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19. Dzhafer N; Papathanasiou JV Folia Med (Plovdiv); 2020 Sep; 62(3):592-596. PubMed ID: 33009760 [TBL] [Abstract][Full Text] [Related]
16. Compassionate Use of Remdesivir for Patients with Severe Covid-19. Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812 [TBL] [Abstract][Full Text] [Related]
17. Use of remdesivir for patients with Covid-19: a review article. Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862 [TBL] [Abstract][Full Text] [Related]
18. Dozens of coronavirus drugs are in development - what happens next? Ledford H Nature; 2020 May; 581(7808):247-248. PubMed ID: 32409766 [No Abstract] [Full Text] [Related]
19. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement. Paladugu S; Donato AA Ann Intern Med; 2020 Jul; 173(2):JC4. PubMed ID: 32687756 [TBL] [Abstract][Full Text] [Related]
20. Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective. Mansuri Z; Shah B; Zafar MK; Jolly T; Jain S Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32470232 [No Abstract] [Full Text] [Related] [Next] [New Search]